Conditions: Hematologic Malignancies; Certain:; Inherited Disorders of Metabolism; Inherited Abnormalities of Erythrocyte Differentiation or Function; Inherited Abnormalities of Platelets; Disorders of the Immune System; Histiocytic Disorders; X-linked Lymphoproliferative Syndrome; Primary Immunodeficiency Diseases; Bone Marrow Failure; Beta-thalassemia Intervention: Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)

Principal Investigator:
Neudorf, Steven

Research Coordinator:
Kathryn Duvall
(714) 509-8646

Visit clinicaltrials.gov for more information about this trial.



  • Clinical Trial Info
  • IRB Number: 110876
  • Sponsor: National Marrow Donor Program (NMDP)
  • Protocol Number: 10-CBA
  • NCT Number: NCT01351545
  • Research Type: Bone Marrow Transplant/Hematopoietic Stem Cell Transplant
  • Phase: NA
  • Status: Active - Open to Enrollment